​AIIMS Patna and SHS Bihar Partner to Launch 13 Regional Medical Colleges Under Statewide Emergency Healthcare

Date:

Share post:

AIIMS Patna and the State Health Society (SHS) Bihar have signed a landmark Memorandum of Understanding (MoU) to establish a standardized, statewide emergency healthcare network across Bihar. The agreement was executed by Brinda Lal (Joint Secretary, SHS Bihar) and Prof. Dr. Prashant Kumar Singh (Medical Superintendent, AIIMS Patna), in the presence of Executive Director Prof. (Brig.) Dr. Raju Agarwal. Key witnesses present during the ceremony included Dr. Jayati Srivastava and Yukta Singh from SHS Bihar, alongside Nilotpal Bal, Dr. Divendu Bhushan (Head, Emergency Medicine), and Dr. Jyoti Prakash (Head, General Medicine & Registrar Academics) from AIIMS Patna.

​Operating on a structured hub-and-spoke model, AIIMS Patna will function as the apex resource center mentoring 13 regional medical colleges and peripheral healthcare facilities across the state. The strategic partnership introduces uniform triage systems, standardized clinical protocols, and mandatory pre-transfer stabilization procedures to optimize care during the critical “Golden Hour” for trauma, cardiac, and obstetric emergencies. 

To ensure seamless execution, the initiative leverages advanced simulation training, tele-ICU support, and digital learning platforms to elevate healthcare standards and transform emergency survival rates statewide.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

ViiV Healthcare Advances HIV Care with Breakthrough Long-Acting Injectable Data at AIDS 2026

ViiV Healthcare, the global specialist HIV company majority-owned by GSK plc, announced landmark clinical, real-world, and pipeline data...

Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India

Wockhardt Limited announced the launch of the Wockhardt Antibiotic Academy, a national initiative dedicated to fostering patient-centric scientific dialogue...

Optimus Pharma Secures Regulatory Approval for Non-Steroidal Tapinarof Cream to Treat Plaque Psoriasis

Optimus Pharma, a leading Indian pharmaceutical manufacturer and subsidiary of Sekhmet Pharmaventures, announced that it has received regulatory...

Enhertu Shows Better Results Than Standard Treatment in Lung Cancer Trial

AstraZeneca and Daiichi Sankyo announced that their antibody-drug conjugate Enhertu (trastuzumabderuxtecan) has achieved a statistically significant and clinically meaningful improvement...